Latest Form 4 insider transactions
NASDAQ
Jeremy R. Graff, See Remarks of Allarity Therapeutics, Inc., reported multiple transactions in common stock on January 22, 2026.
NASDAQ
Srivastava Sudhir, Chairman and CEO, a Director and 10% owner of SS Innovations International, Inc., reported a transaction in 50,000 shares of common stock on October 9, 2026.
NASDAQ
CRNC
Cerence INCAntonio Rodriquez, CFO of Cerence Inc., reported multiple transactions in common stock on February 15, 2026.
NASDAQ
Robinhood Markets, Inc. reported changes in beneficial ownership of Robinhood Markets, Inc. common stock on October 7, 2026.
NYSE
Robinhood Markets, Inc. reported changes in beneficial ownership of Robinhood Ventures Fund I common stock on October 7, 2026.
NASDAQ
OKTA
Okta, INCForm 4: Okta Executive Sells Shares
Shibu Ninan, Chief Accounting Officer of Okta, Inc., sold 14,677 shares of common stock on October 7, 2026.
Stephen W. Beard, Chairman & CEO of Adtalem Global Education Inc., sold 8,306 shares of common stock on October 8, 2026.
NASDAQ
CRNC
Cerence INCForm 4: Cerence CEO Sells Shares
Brian M Krzanich, Chief Executive Officer and a Director of Cerence Inc., sold 21,703 shares of common stock on October 7, 2026 for $8.00 per share.
NASDAQ
CRNC
Cerence INCForm 4: Cerence Executive Sells Shares
Christian Mentz, EVP, Chief Revenue Officer of Cerence Inc., sold 48,923 shares of common stock on October 7, 2026 for $8.00 per share.
Frederick Blair Wimbush, a Director of Armada Hoffler Properties, Inc., purchased 1,127 shares of common stock on October 7, 2026.
NASDAQ
IMVT
Immunovant, INCForm 4: Immunovant CTO Sells Shares
Jay S Stout, Chief Technology Officer of Immunovant, Inc., sold 3,809 shares of common stock on October 7, 2026 for $32.06 per share.
Theodore Bigman, a Director of Armada Hoffler Properties, Inc., purchased 1,879 shares of common stock on October 8, 2026 for $5.96 per share.
Form 4: Block Director Sells Shares
Anthony Mathew Eisen, a Director of Block, Inc., sold 18,000 shares of common stock on October 7, 2026.
NASDAQ
IMVT
Immunovant, INCTuyl Christopher Van, Chief Legal Officer of Immunovant, Inc., sold 1,327 shares of common stock on October 7, 2026 for $32.06 per share.
NASDAQ
Samak L Azar, Chief Legal Officer of GLOBALFOUNDRIES Inc., sold 335 shares of common stock on October 8, 2026 for $49.01 per share.
NASDAQ
CRNC
Cerence INCForm 4: Cerence Executive Sells Shares
Jennifer Salinas, EVP Chief Admin Officer of Cerence Inc., sold 66,153 shares of common stock on October 7, 2026 for $8.00 per share.
NASDAQ
NVDA
Nvidia CORPTench Coxe, a Director of Nvidia Corp, reported a transaction in 500,000 shares of common stock on October 7, 2026.
NASDAQ
IMVT
Immunovant, INCForm 4: Immunovant COO Sells Shares
Melanie Gloria, Chief Operating Officer of Immunovant, Inc., sold 2,241 shares of common stock on October 7, 2026 for $32.06 per share.
NASDAQ
CRNC
Cerence INCForm 4: Cerence Executive Sells Shares
Nils Schanz, EVP Product & Technology of Cerence Inc., sold 52,439 shares of common stock on October 7, 2026 for $8.00 per share.
NYSE
Form 4: Accenture COO Sells Shares
Catherine Kiernan Hogan, Chief Operating Officer of Accenture plc, sold 1,320 shares of common stock on October 8, 2026 for $200.00 per share.
NYSE
Nikhil Chandhok, Chief Product & Tech. Officer of Circle Internet Group, Inc., sold 26,668 shares of common stock on October 8, 2026 for $79.59 per share.
NASDAQ
NTNX
Nutanix, INCForm 4: Nutanix Director Sells Shares
Teresa Gayle Sheppard, a Director of Nutanix, Inc., sold 3,500 shares of common stock on October 9, 2026.
NASDAQ
DDOG
Datadog, INCForm 4: Datadog CTO Sells Shares
Alexis Le-Quoc, Chief Technology Officer and a Director of Datadog, Inc., sold 53,912 shares of common stock on October 7, 2026.
NYSE
Medtronic plc is offering to exchange newly issued shares of MiniMed Group, Inc. for its own common stock as part of a strategic restructuring.
NYSE
Paul M. Dicicco, EVP, CFO & Treasurer of Madison Square Garden Sports Corp., received 813 shares of common stock on August 26, 2026.
NASDAQ
BNTX
Biontech SEForm 4: BioNTech SE CEO Sells Shares
Ugur Sahin, Chief Executive Officer and 10% owner of BioNTech SE, sold 63,209 shares of common stock on October 8, 2026.
NASDAQ
Liang Chiu-Chu Sara Liu, a Director and 10% owner of Super Micro Computer, Inc., sold 100,000 shares of common stock on October 7, 2026 for $45.02 per share.
NASDAQ
Charles Liang, President and CEO, a Director and 10% owner of Super Micro Computer, Inc., sold 100,000 shares of common stock on October 7, 2026 for $45.02 per share.
NASDAQ
Thomas Sternweis, SVP, Enterprise Dev. & Strat. of Honest Company, Inc., sold 25,000 shares of common stock on October 8, 2026 for $4.90 per share.
NASDAQ
Donald W Slager, a Director of WillScot Holdings Corp, received 6,397 shares of common stock on October 7, 2026.